ГОСТ IS 010993-7— 2011
(61]LONG. G.L. and WINEFORDNER. J.D. Limit of detection — A closer look at the IUPAC definition. Anal. Chem. 55(7)
1983: pp. 712A—724A
(62] LYNCH. D.. LEWIS. T.. MOORMAN. W.. SABHARWAL. P. and BURG. J. Toxic and mutagenic effects of ethyleneoxide
and propylene oxide on spermatogenic functions in Cynomolgus monkeys. Toxicologist. 3:60
(63] LYNCH. D.. LEWIS. T. MOORMAN. W.. BURG. J.. GROTH. D.. KHAN. A.. ACKERMAN. L. and COCKERELL. B. Carci
nogenic and toxicologic effects of inhaled ethylene oxide and propylene oxide in F344 rats. Tox. Appl. Pharm. 76
1984: pp. 6 9 -8 4
(64] MALANOSKI. A.J. Analyst performance standards: Determination for and from collaborative studies. J. Assoc. Off.
Anal. Chem. 65{6) 1982; pp. 1333—1338
(65] MANIUS, G.J. Determination of ethylene oxide, ethylene chlorohydrin. and ethylene glycol residues in ophthalmic
solution at proposed concentration limits. J. Pharm. Sci. 68(12) 1979; pp. 1547— 1549
(66] MARLOWE. D.E., LAO. N.T.. LAO. C.S.. EATON, A.R. and PAGE. B.F.J. InterlaboratoryComparison of EthyleneOxide
Residue Analysis Test Methods (HHS Publication FDA 86-4204). Mar. 1986
(67] MARLOWE. D.E. Summary of results from intertaboratory comparison of ethylene oxide residue analysis test
methods. Paper presented at AAMI Conference on In-hospital EO Sterilization. Arlington. Virginia. Nov. 1983
(68] MARLOWE. D.E., LAO. N.T., EATON. A.R.. PAGE. B.F.J. and LAO. C.S. An Interlaboratory comparison of analytical
methods for ethylene oxide. J. Pharm. Sd. 76 1986; pp. 333— 337
(69] MASON. M.. CATE. C. and BAKER. J. Toxicology and carcinogenesis of various chemicals used in the preparation
of vacdnes. C/in. Toxicol. 4(2) 1971; pp. 185—204
(70] MATSUMOTO.T . HARDAWAY. R.M.. PANI. K.C.. SATER. C.M.. BARTAK. D.E. and MARGETIS. P.M. Safe standard of
aeration for ethylene oxide sterilized supplies. Arch. Surg. 96 1968: pp. 464—470
(71] MCDONALD. T. ROBERTS. M. and BORGMANN. A. Ocular toxicity of ethylene chlorohydrin and ethylene glycol in
rabbit eyes. Tox. Appl. Pharm. 21 1972: pp. 143— 150
(72] MCDONALD. T. KASTEN. K.. HERVEY. R.. GREGG. S.. BORGMANN. A. and MURCHESON. T. Acute oculartoxidty
of ethylene oxide, ethylene glycol and ethylene chlorohydrin. Bull. Parent. Drug Assoc. 27(4) 1973; pp. 153— 164
(73] MCDONALD. T. KASTEN. K.. HERVEY. R.. GREGG. S. and BUTTON. B. Acute ocular toxicityfor normal and irritated
rabbit eyes and subacute ocular toxidty for ethylene oxide, ethylene chlorohydrin and ethylene glycol. Bull. Parent.
Drug Assoc. 31(1) 1977; pp. 25—32
(74] MOGENHAN. J.A.. WHITBOURNE. J.E. and ERNST. R.R. Determination of ethylene oxide in surgical materials by
vacuum extraction and gas chromatography. J. Pharm. Sd. 60(2) 1971; pp. 222—224
(75] MORRIS. T. NELSON. M. and CALVERY, A. Observations on the chronic toxicities of propylene glyco ethylene
glycol, diethylene glycol, ethytene glycol mono-ethyl-ether, and diethylene glycol mono-methyl-ether. J. Pharm.
Exp. Ther. 74 1942: pp. 266—273
(76} MUZENI. R.J. Rapid gas chromatographic determination of ethylene oxide, ethylene chlorohydrin. and ethylene
glycol residues in rubber catheters. J. Assoc. Off. Anal. Chem. 68(3) 1985; pp. 506—508
[77] NAKAMURA. A.. KIKUCHI, H. and TSUJI, K. Determination of ethylene oxide residue in commercially available
intraocular lenses by new sensitive method (Electron capture detectionigas chromatography). IOL. 3 1989: pp. 4— 8
[78] NORTHUP. S.. WEINCKOWSKI, D„ MARTIS. L. and DARBY. T. Toxidty caused by acute and subacute intravenous
administration of ethylene oxide in the rat. J. Environ. Pathol. Toxicol. 5 1981: pp. 617—623
[79] National Toxicology Program. Toxicology and Carcinogenicity Studies of 2-Chloroethanol (Ethylene Chlorohydrin)
(CAS. No. 107-07-03) in F344,’N Rats and Swiss CD-1 Mice (Dermal Studies) (NTP TR275. NIH Publication 86-2531).
Research Triangle Park. NC: NTP. 1985
[80] National Toxicology Program. Toxicology and Carcinogenicity Studies of Ethylene Oxide (CAS No. 75-2 1-8) in
B6C3F 1 Mice (Inhalation Studies) (NTP Technical Report 326. U.S. Department of Health and Human Services.
Public Health Services. National Institute of Health). Research Triangle Park. NC: NTP. 1987
[81] OBA. T, TSUJI. K.. MIZUMACHI, S.. KIKUCHI. H., SHINTANI. H.. IIDA. K. and MEGURO. K. Studies on residual
ethylene oxide in medical devices (I) — Gas chromatographic determination of ethytene oxide in plastics. Ikakikai-
gaku. 52(3) 1982: pp. 134— 139
[82] OHBA T. Safety of residual ethylene oxide and ethylene oxide concentrations in the working environment of
sterilization facilities. In: Gaughren. E.; Morrissey. R.; You-sen. W.. (Eds.). Sterilization of Medical Products Volume IV.
Montreal. Canada: Polyscience Publications, Inc.. 1986: pp. 172— 177
[83] OSER. B.. MORGAREIDGE. K.. COX. G. and CARSON. J. Short-term toxicityofethylene chlorohydrin (ECH) in rats,
dogs and monkeys. Fd. Cosmet. Tox. 13 1975: pp. 313— 315
[84] PATEL. A. (unpublished data presented to ISO/ТС 194/WG 11 byA Patel. Alcon Laboratories. Inc. and his colleagues
at the WG meeting in Minneapolis. MN. Sept. 1993)
[85] Pharmaceutical Manufacturers’ Association. Procedures for setting limits for volatile organic solvents with methylene
chloride as an example of the process. Committee on Rational Specifications for Impuribes in Bulk Drug Substances —
Parmaceutical Manufacturers’ Association. In: Pharmacopeial Forum. Washington. DC: PMA. Nov.-Dee. 1989:
pp. 5748—5759
36